Key facts
- Jeeva Clinical Trials’s last known valuation is $9.1M (Dec 2024).
- It has raised $1.4M.
- Notable investors include US National Science Foundation, Team Ignite Ventures, Virginia Innovation Partnership Corporation, Virginia Venture Partners, IGNITE - Grant — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Jeeva Clinical Trials
- ·The full record, as it builds
Funding rounds
No funding rounds for Jeeva Clinical Trials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jeeva Clinical Trials
Developer of a clinical trial management platform designed to unify and streamline trial operations. The company's platform offers integrated modules for data capture, consent, scheduling and workflow automation with artificial intelligence support, enabling sponsors, contract research organizations, and research sites to manage clinical trials with improved coordination and oversight.
- Sector
- Healthcare
- HQ
- Manassas, VA, United States
- Founded
- 2019
- Employees
- 18
- Website
- jeevatrials.com/
- Ownership
- Privately Held (backing)
Jeeva Clinical Trials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jeeva Clinical Trials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jeeva Clinical Trials in its N-PORT filings yet. We sweep new filings monthly.